Mon - Fri 9AM-5PM +1-407-776-9217

Diverse DNA

Why Diverse DNA

Committed to Making a Difference
In each of the divisions of Diverse Biotech, including Diverse DNA, we are combining our experience, scientific research and business acumen to do more of what we’re passionate about: improving health and improving lives.

Improving Health and Wellness

Each person’s cancer has a unique combination of genetic changes, and tumor DNA sequencing is a test to identify these unique DNA changes. In some cases, knowledge of the genetic alterations in a cancer can help determine a treatment plan. Our Diverse DNA cancer screening division has multiple oncology practices across the country where samples are collected and tested for DNA mutations that give insight to oncologist for heading off cancer before it becomes life threatening to their patients.

Our Diverse DNA division provides meticulousness, next-generation DNA sequencing tools, to arm physicians and patients with personalized treatment information 

Genomic Testing

We assist our clients with specialty genomic testing, including:

  • Hereditary Cancer Screenings (CGX)to understand if a patient is predisposed to acquiring cancer

  • Pharmacogenomics Testing (PGX) – to show how a patient’s body is likely to metabolize many common medications.

More on CGX

CGX screening offers physicians a full panel of genomics, enabling oncologists to better understand the disease, its structure, function, evolution, mapping, and editing of genomes. Taking the CGX test allows the patient to be proactive and learn as early as possible what changes need to be made if they are more pre-disposed to acquiring cancer.

According to, in 2018 there were approximately 1,735,350 newly diagnosed cancer cases and 609,640 cancer deaths, just in the United States.

More on PGX

With billions of prescriptions dispensed each year in the United States alone, it is estimated that sixty percent of patients are commonly prescribed medications that do not work as intended. With adverse reactions ranging from ineffectiveness of dose, to hospitalization and even death, patients often take medications on a trial-and-error basis. This margin for error requires close physician monitoring, repeat blood work and potentially unpleasant side effects.

PGX testing allows physicians to more confidently prescribe medications. It also assists patients in avoiding adverse drug reactions and benefit from maximize drug efficacy.

Cancer Screenings

Diverse DNA, a division of Diverse Biotech synergizes the teams specialized knowledge, partnerships and cutting edge DNA sequencing tests provide our clients with best-in-class solutions. We are committed to providing a full range of DNA sequencing tests with a mission to extend or save lives. That’s our biggest goal.

Buccal Swab Program

Diverse DNA’s buccal swab program advances research capabilities with cutting-edge technology to improve patient care and cancer treatment through early detection. Diverse DNA’s cancer screenings are a preventative cancer strategy.

Our cancer-screening program is compromised of lab techs, administrative personnel, and DNA sequencing technology, but it offers something more – a team who care.

Additional DNA Tests Offered

In addition to the genetic testing, we also offer comprehensive health and wellness tests such as:

  • Wound Cultures - to identify bacteria in wounds
  • Lipid Panels – to analyze levels of LDL, HDL, triglycerides and total cholesterol
  • Nail Testing – to show a history of drug use
  • Bloodborne Pathogens Testing – to identify infectious microorganisms in human blood that can cause disease in humans
  • STD Tests– to detect organisms that cause sexually transmitted diseases
  • Fungal Tests – to detect and identify fungi in order to diagnose infections and help guide treatment
  • Tissue Culture Development – to detect infection.